0.60Open0.60Pre Close0 Volume4 Open Interest10.00Strike Price0.00Turnover233.75%IV46.19%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier21DDays to Expiry0.60Extrinsic Value100Contract SizeAmericanOptions Type-0.1002Delta0.0180Gamma29.12Leverage Ratio-0.0408Theta-0.0012Rho-2.92Eff Leverage0.0074Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet